Opdyta 40mg Injection
By Opdyta
Rx
4ml Injection in a Vial

Composition
Nivolumab(40mg)

Manufacturer - BMS India Pvt Ltd
Bristol-Myers Squibb India Pvt. Ltd., The India Bulls Finance Centre, 6th Floor, Tower 1, Senapati Bapat Marg, Elphinstone (W), Mumbai - 400013

Expires on or after
April, 2026

liver
Opdyta 40mg Injection is considered safe for use in patients who have liver disease. It is important to note that no dose adjustment of Opdyta 40mg Injection is necessary specifically for individuals with liver issues. Be sure to follow all instructions provided by your healthcare provider when using this medication. If you have concerns about using Opdyta 40mg Injection in relation to your liver condition, do not hesitate to consult your doctor for personalized guidance and advice.

kidney
Opdyta 40mg Injection is safe to use in patients with kidney disease, with no recommended dose adjustment needed.

alcohol
Consult your doctor when consuming alcohol with Opdyta 40mg Injection.

driving
Opdyta 40mg Injection typically does not impact your driving ability.

pregnancy
Opdyta 40mg Injection is considered unsafe during pregnancy due to the risk of harm to the baby. However, in life-threatening situations, a doctor may prescribe it if the benefits outweigh the risks. It is important to consult your doctor before using this medication during pregnancy.

breastfeeding
Opdyta 40mg Injection may not be safe during breastfeeding as it can pass into breastmilk and potentially harm the baby. It is advisable to consult your healthcare provider before using this medication while breastfeeding.
Habit Forming | No |
Chemical Class | Monoclonal Antibody |
Therapeutic Class | - |
Action Class | Programmed Cell Death 1 (PD-1) Checkpoint Inhibitors |
₹39800
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025